Peng Gu Selected Research

Peng Gu Research Topics

Disease

27	Neoplasms (Cancer) 05/2024 - 02/2015
12	Urinary Bladder Neoplasms (Bladder Cancer) 01/2022 - 02/2015
11	Prostatic Neoplasms (Prostate Cancer) 03/2023 - 03/2014
8	Hepatocellular Carcinoma (Hepatoma) 05/2022 - 05/2014
5	Carcinogenesis 02/2022 - 08/2016
5	Neoplasm Metastasis (Metastasis) 12/2021 - 05/2014
3	Renal Cell Carcinoma (Grawitz Tumor) 09/2023 - 01/2017
3	Carcinoma (Carcinomatosis) 01/2023 - 01/2022
3	Liver Neoplasms (Liver Cancer) 01/2022 - 07/2016
3	Lymphatic Metastasis 03/2021 - 10/2017
2	Sepsis (Septicemia) 12/2023 - 10/2023
2	Liver Failure 12/2023 - 11/2023
2	Tyrosinemias (Tyrosinemia) 11/2023 - 06/2021
2	Obesity 09/2023 - 09/2022
2	Graves Disease (Basedow Disease) 09/2023 - 01/2023
2	Hyperthyroidism 01/2023 - 04/2020
2	Multiple Trauma (Multiple Injuries) 11/2022 - 01/2021
2	Shock 11/2022 - 01/2022
2	Wounds and Injuries (Trauma) 11/2022 - 08/2022
2	Cholangiocarcinoma 02/2022 - 01/2022
2	Tics (Tic) 01/2021 - 08/2013
1	Rectal Neoplasms (Rectal Cancer) 02/2024
1	Bone Resorption 01/2024
1	Endophthalmitis (Ophthalmia) 12/2023
1	Retinal Detachment (Retinal Detachments) 12/2023
1	Acute Liver Failure (Fulminant Hepatic Failure) 12/2023
1	Chronic Periodontitis 09/2023
1	Osteoporosis 09/2023
1	Hypertension (High Blood Pressure) 09/2023
1	Anemia 09/2023
1	Leukopenia 09/2023
1	Nausea 09/2023
1	Neutropenia 09/2023
1	Vomiting 09/2023
1	Thrombocytopenia (Thrombopenia) 09/2023
1	Vitamin D Deficiency 01/2023
1	Hypothyroidism 01/2023
1	Pulmonary Arterial Hypertension 01/2023

Drug/Important Bio-Agent (IBA)

8	Long Noncoding RNAIBA 01/2022 - 01/2017
5	Biomarkers (Surrogate Marker)IBA 09/2023 - 02/2015
4	Polypyrimidine Tract-Binding ProteinIBA 03/2021 - 01/2017
4	AndrogensIBA 01/2019 - 05/2016
3	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 02/2015
3	Small Interfering RNA (siRNA)IBA 11/2017 - 03/2014
3	Proteins (Proteins, Gene)FDA Link 05/2016 - 03/2014
2	Immune Checkpoint InhibitorsIBA 05/2024 - 01/2022
2	Retinaldehyde (Retinal)IBA 12/2023 - 11/2021
2	fumarylacetoacetase (fumarylacetoacetate hydrolase)IBA 11/2023 - 06/2021
2	Coffee FDA Link 09/2023 - 01/2022
2	CalciumIBA 09/2023 - 11/2017
2	Sorafenib (BAY 43-9006)FDA Link 09/2023 - 11/2016
2	Messenger RNA (mRNA)IBA 09/2023 - 01/2019
2	Thyroxine (Levothyroxine)FDA LinkGeneric 01/2023 - 04/2020
2	MicroRNAs (MicroRNA)IBA 02/2022 - 05/2014
2	Circular RNAIBA 02/2022 - 01/2022
2	Cyclin D1IBA 02/2022 - 01/2017
2	Fluorouracil (Carac)FDA LinkGeneric 12/2021 - 01/2021
2	Cyclin-Dependent Kinases (cdk Proteins)IBA 12/2021 - 01/2021
2	Indicators and Reagents (Reagents)IBA 01/2021 - 08/2014
2	Hormones (Hormone)IBA 10/2017 - 03/2014
2	TOR Serine-Threonine KinasesIBA 08/2016 - 05/2015
2	Cyclin B1IBA 06/2015 - 02/2015
1	corylifol AIBA 01/2024
1	LipopolysaccharidesIBA 12/2023
1	Acetaminophen (Paracetamol)FDA LinkGeneric 12/2023
1	Cytochrome P-450 CYP2E1 (CYP2E1)IBA 12/2023
1	EnzymesIBA 12/2023
1	Tyrosine (L-Tyrosine)FDA Link 11/2023
1	phenylpyruvic acidIBA 10/2023
1	SeleniumIBA 09/2023
1	CopperIBA 09/2023
1	IronIBA 09/2023
1	MineralsIBA 09/2023
1	MagnesiumIBA 09/2023
1	ZincIBA 09/2023
1	Sunitinib (Sutent)FDA Link 09/2023
1	Glutamine (L-Glutamine)FDA Link 03/2023
1	embelinIBA 01/2023
1	Lapatinib (GW572016)FDA Link 01/2023
1	bicalutamide (Casodex)FDA LinkGeneric 01/2023
1	RNA (Ribonucleic Acid)IBA 01/2023
1	LipidsIBA 01/2023
1	Uric Acid (Urate)IBA 01/2023
1	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 01/2023
1	Endothelin Receptor AntagonistsIBA 01/2023
1	Phosphodiesterase 5 InhibitorsIBA 01/2023
1	Fulvestrant (Faslodex)FDA Link 01/2023
1	selexipagIBA 01/2023
1	Estrogen ReceptorsIBA 01/2023

Therapy/Procedure

7	Therapeutics 05/2024 - 05/2015
5	Drug Therapy (Chemotherapy) 01/2023 - 05/2015
4	Castration 12/2021 - 01/2017
2	Immunotherapy 05/2024 - 01/2022
2	Ligation 12/2023 - 10/2023
2	Punctures 12/2023 - 10/2023
2	Oral Administration 01/2023 - 08/2016
2	Splenectomy 11/2022 - 08/2022
1	Neoadjuvant Therapy 02/2024
1	Vitrectomy 12/2023
1	Prostatectomy (Retropubic Prostatectomy) 01/2023